Home › Juvenile Myelomonocytic Leukemia › California › San Francisco
Juvenile Myelomonocytic Leukemia clinical trials in San Francisco, CA
3 studies for Juvenile Myelomonocytic Leukemia are looking for participants at sites in and around San Francisco (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Phase I/II Study of Trametinib and Azacitidine for Patients With Newly Diagnosed Juvenile Myelomonocytic Leukemia
RecruitingPhase 1/2
- University of California San Francisco, San Francisco
A Study to Find the Highest Dose of Imetelstat in Combination With Fludarabine and Cytarabine for Patients With AML, MDS or JMML That Has Come Back or Does Not Respond to Therapy
RecruitingPhase 1
- UCSF Medical Center-Mission Bay, San Francisco
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
RecruitingPhase 1/2
- UCSF Medical Center-Mission Bay, San Francisco
Juvenile Myelomonocytic Leukemia trials in other cities
- Minneapolis, MN4 studies
- Philadelphia, PA4 studies
- Boston, MA3 studies
- New York City, NY3 studies
- Washington, DC3 studies
- Indianapolis, IN3 studies
- Atlanta, GA3 studies
- Chicago, IL3 studies
- Ann Arbor, MI3 studies
- Cincinnati, OH3 studies
- Memphis, TN3 studies
- Seattle, WA3 studies
Other studies in San Francisco
- Prostate Cancer45 studies
- Breast Cancer43 studies
- Non-Small Cell Lung Cancer36 studies
- Cancer (all types)35 studies
- Heart Failure29 studies
- Metastatic Cancer28 studies
- Lung Cancer22 studies
- Melanoma22 studies
- Pancreatic Cancer20 studies
- Ovarian Cancer19 studies
- Colorectal Cancer18 studies
- Cardiovascular Disease18 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.